34521135|t|Thoracic Paravertebral Block Ameliorates Postoperative Delirium in Geriatric Patients.
34521135|a|OBJECTIVES: Thoracic surgery often causes postoperative delirium (POD) in geriatric patients. This study aimed to explore the effect of ultrasound-guided continuous thoracic paravertebral block (UG-TPVB) on POD in geriatric patients undergoing pulmonary resection. METHODS: Total 128 patients who underwent pulmonary resection were randomly allocated to either the conventional patient-controlled analgesia (PCA) group or the UG-TPVB group (n = 64 per group). The consumption of opioid agents (propofol and remifentanil), postoperative hospital stay, postoperative pulmonary atelectasis, postoperative nausea/vomiting, and postoperative itchiness were recorded. The diagnosis of delirium was dependent on the Nursing Delirium Screening Scale. The postoperative pain was assessed by visual analogue scale (VAS) score. The serum levels of interleukin (IL)-1beta, IL-6, and tumor necrosis factor-alpha were used to evaluate the postoperative neuroinflammation. RESULTS: The consumption of propofol and remifentanil, postoperative hospital stay, postoperative pulmonary atelectasis, postoperative nausea/vomiting, and postoperative itchiness in the UG-TPVB group were lower than that in the PCA group. Compared with the PCA group, the prevalence of POD was decreased in the UG-TPVB group. In addition, use of UG-TPVB not only reduced postoperative pain (VAS score) but also decreased postoperative neuroinflammation compared with PCA in geriatric patients undergoing pulmonary resection. CONCLUSIONS: This study determined the benefits of UG-TPVB over PCA, providing an effectiveness approach to alleviate POD in geriatric patients undergoing pulmonary resection.
34521135	9	22	Paravertebral	Chemical	-
34521135	41	63	Postoperative Delirium	Disease	MESH:D000071257
34521135	77	85	Patients	Species	9606
34521135	129	151	postoperative delirium	Disease	MESH:D000071257
34521135	153	156	POD	Disease	MESH:D000071257
34521135	171	179	patients	Species	9606
34521135	261	274	paravertebral	Chemical	-
34521135	285	289	TPVB	Chemical	-
34521135	294	297	POD	Disease	MESH:D000071257
34521135	311	319	patients	Species	9606
34521135	371	379	patients	Species	9606
34521135	465	472	patient	Species	9606
34521135	516	520	TPVB	Chemical	-
34521135	581	589	propofol	Chemical	MESH:D015742
34521135	594	606	remifentanil	Chemical	MESH:D000077208
34521135	638	673	postoperative pulmonary atelectasis	Disease	MESH:D001261
34521135	675	704	postoperative nausea/vomiting	Disease	MESH:D020250
34521135	710	733	postoperative itchiness	Disease	MESH:D019106
34521135	766	774	delirium	Disease	MESH:D003693
34521135	804	812	Delirium	Disease	MESH:D003693
34521135	834	852	postoperative pain	Disease	MESH:D010149
34521135	924	946	interleukin (IL)-1beta	Gene	3553
34521135	948	952	IL-6	Gene	3569
34521135	958	985	tumor necrosis factor-alpha	Gene	7124
34521135	1026	1043	neuroinflammation	Disease	MESH:D000090862
34521135	1073	1081	propofol	Chemical	MESH:D015742
34521135	1086	1098	remifentanil	Chemical	MESH:D000077208
34521135	1129	1164	postoperative pulmonary atelectasis	Disease	MESH:D001261
34521135	1166	1195	postoperative nausea/vomiting	Disease	MESH:D020250
34521135	1201	1224	postoperative itchiness	Disease	MESH:D019106
34521135	1235	1239	TPVB	Chemical	-
34521135	1332	1335	POD	Disease	MESH:D000071257
34521135	1360	1364	TPVB	Chemical	-
34521135	1395	1399	TPVB	Chemical	-
34521135	1417	1435	postoperative pain	Disease	MESH:D010149
34521135	1481	1498	neuroinflammation	Disease	MESH:D000090862
34521135	1530	1538	patients	Species	9606
34521135	1625	1629	TPVB	Chemical	-
34521135	1689	1692	POD	Disease	MESH:D000071257
34521135	1706	1714	patients	Species	9606
34521135	Association	MESH:D000090862	7124
34521135	Association	MESH:D000090862	3553

